DiaMedica Therapeutics (DMAC)
(Real Time Quote from BATS)
$2.88 USD
+0.03 (1.05%)
Updated May 24, 2024 01:36 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, DiaMedica Therapeutics (DMAC) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 12.50%. Look out for DMAC's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for DMAC
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services